A cutaneous pseudolymphoma may develop at the site of vaccination months or years after the event.
(1) Skin lesion at the site of a vaccination.
(2) Biopsy of the lesion shows a dense lymphoid infiltrate in the dermis and possibly subcutaneous tissue.
(3) Evaluation of the lesion shows a polyclonal proliferation of T and B cell lymphocytes.
(4) Aluminum deposits identified in the histologic sections and/or evidence of aluminum hydroxide used as an adjuvant in the vaccine used.
(1) cutaneous lymphoma developing at the site
(2) pseudolymphoma from another cause (such as a bug bite)
(3) other kind of lymphoid infiltrate
To read more or access our algorithms and calculators, please log in or register.
Specialty: Infectious Diseases, Pharmacology, clinical